Vanda Can See FDA Docs On Drug Label Denial, Judge Says
The U.S. Food and Drug Administration did not satisfy its obligation to show "foreseeable harm" in releasing internal reviews to explain its denial of a label expansion for a Vanda Pharmaceuticals...To view the full article, register now.
Already a subscriber? Click here to view full article